NF2 BIOSOLUTIONS SEEKING A CURE OR PREVENTATIVE TREATMENT FOR NF2 BY VIGOROUSLY SUPPORTING AND ADVANCING EXISTING AND NEXT GENERATION BIOMEDICAL TECHNOLOGIES SUCH AS GENE TRANSFER THERAPY AND IMMUNONTHERAPY
NF2 BIOSOLUTIONS has received 23 grants from 14 known foundation funders. Revenue decreased from $772,336 in 2023 to $226,008 in 2024. Most recent reported revenue: $226,008.
Annual Revenue
$226,008
Known Funders
14
Grants Received
23
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $226,008 | $316,809 | $621,589 |
| 2023 | $772,336 | $966,416 | $712,390 |
| 2022 | $418,620 | $308,337 | $906,470 |
| 2021 | $544,244 | $386,234 | $796,187 |
| 2020 | $708,384 | $537,191 | $638,177 |
Top Funders
NEW ALBANY, IN
Washington, DC
Washington, DC
SOUTHEASTERN, PA
SOUTHEASTERN, PA
MIAMI, FL
Washington, DC
ALEXANDRIA, VA
Wilmington, DE
Wilmington, DE
Showing top 10 of 14 funders.
Key Personnel
From 2024 IRS 990 filing
NICOLE HENWOOD
PRESIDENT
GILLES ATLAN
VICE PRESIDENT
VITO GRASSO
DIRECTOR
CHRIS SERLE
DIRECTOR
AMY WILLIAMS
DIRECTOR
DEIAN OWEN
TREASURER
MARY SELL
DIRECTOR
JILL VELEZ
SECRETARY
CLAUDIA SCHMIDT
DIRECTOR
Frequently Asked Questions
Other Nonprofits in Pennsylvania
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.